The estimated size of the global market for digital diabetes management is 15.06 billion in 2022 and is expected to grow at a compound annual growth rate of 11.54% to reach 39.54 billion by 2031.
The global digital diabetes management market was valued at USD 6,960.0 million in 2019 and is expected to grow at a CAGR of 22.9% over the forecast period. Increasing prevalence of diabetes, technological advancements, and increasing penetration of digital platforms especially across emerging economies are anticipated to fuel market growth of the global digital diabetes management market.
Key players serving the global Digital Diabetes Management market include Abbott, Medtronic, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., BD, Dexcom, Inc., Ascensia Diabetes Care Holdings AG, Lifescan, Inc., Glooko, Inc., Tandem Diabetes Care among other prominent players.
Digital Diabetes Management Market Scope
|Revenue forecast in 2031
|USD 39.54 billion
|CAGR of 11.54 % during 2021-2031
|Product, Type, By End User, Regions
|North America, Europe, Asia Pacific, South America, Middle East and Africa
|Key Players Profiled
|Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd., Bayer AG, Lifescan, Inc., Dexcom, Inc., Sanofi
Key Segment Of The Digital Diabetes Management Market
Product (USD Billion)
o Smart Glucose Meter
o Continuous Blood Glucose Monitoring System
o Smart Insulin Pens
o Smart Insulin Pumps
• Digital Diabetes Management Apps
• Weight & Diet Management Apps
Type, (USD Billion)
• Wearable Devices
• Handheld Devices
End Use, (USD Billion)
• Home settings
• Diagnostic Centers
Regional Overview, (USD Billion)
• Rest of Europe
• Rest of Asia Pacific
• Rest of South America
Middle East and South Africa
Frequently Asked Questions (FAQ) :
Digital health technology and health applications are rapidly evolving to help people manage their diabetes. There are various health-related applications available on smartphones and other portable devices to help people with diabetes who need to take either lifestyle changes or adjustments to the medicine in response to glucose monitoring. However, to standardize how mobile health applications are checked & regulated for patient safety, legislation & standards have not kept pace with the emerging sector. The evidence available on the safety and efficacy of mobile health applications remains limited, particularly for diabetes.
Mobile applications designed to monitor health & wellbeing in the U.S. & Europe are largely unregulated unless they fulfill the criteria of medical devices for diagnostic purposes. International bodies, including the International Medical Device Regulators Forum and the World Health Organization, have made headway in classifying various forms of digital health technology and incorporating digital health technology into the medical device market.
The digital diabetes management market has enormous potential, given that over 2.5 billion individuals use smartphones and approximately 0.5 billion people are currently using mobile-based applications for the management of diet and chronic diseases. Currently, several applications are stand-alone; however, there is a growing demand for integration and increased automation of data collection and algorithm-based response. Adroit Market Research anticipates that as this trend gain momentum, the landscape of digital diabetes management applications is likely to transform towards greater integration.
Based on type, the global digital diabetes management market is segmented into handheld devices and wearable devices. In the year 2019, wearable devices accounted for the majority of the market share. This is attributed to the advancement in the technology and growing preference for wearable devices in comparison with handheld devices.
North America dominated the global digital diabetes management devices market in the year 2019 owing to the presence of a large patient pool suffering from diabetes. According, to the American Diabetes Association in the year 2018, 34.2 million Americans were having diabetes which equates to 10.5% of the total population. The percentage of Americans age 65 and older remains high, at 26.8%, or 14.3 million seniors (diagnosed and undiagnosed). Furthermore, annually there is an increase of 1.5 patients diagnosed with diabetes. Adroit Market Research further predicts that the favorable reimbursement scenarios over the forecast period will fuel market growth.
Asia Pacific region, on the other hand, is anticipated to witness the highest CAGR over the forecast period owing to growing healthcare facilities, rising government expenditure towards the betterment of healthcare facilities, rising healthcare awareness among the general public. The digital diabetes management market is anticipated to proliferate at a rapid pace across emerging economies of China and India owing to growing digitization trends and growing healthcare e-commerce sector across the region among other contributing factors.